Article
Holland & Knight Health Dose: July 28, 2026
Congress advances defense and government funding measures as the Trump Administration signals potential tariffs on generic drugs. Meanwhile, federal agencies release new AI frameworks, healthcare regulations, and digital health initiatives that could reshape biomedical research and clinical trial design.
Holland & Knight